The Use of Sublingual Melatonin Premedication in Geriatric Cataract Surgery
Recruiting · NCT07036367 · Interventional (participants receive a specific treatment) · Lead sponsor: Al-Azhar University
View the official record on ClinicalTrials.gov →Interventions studied
Sublingual MelatoninSublingual Placebo
What this trial is about
Cataract surgery is routinely performed with anesthesia care, whereas anesthesia care for other elective, low-risk, outpatient procedures is applied more selectively. We hypothesize that sublingual melatonin will provide superior anxiolysis and sedation while maintaining a high safety profile and minimizing hemodynamic disturbances.
Who can take part
Age range
60 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- • Age ≥ 60 years
- American Society of Anesthesiologists (ASA) physical status I-III
- Scheduled for unilateral cataract surgery under local anesthesia
- Ability to understand and complete study-related questionnaires
Exclusion criteria
- • Known allergy or hypersensitivity to melatonin
- Chronic use of sedatives, hypnotics, or anxiolytics
- History of sleep disorders or psychiatric illness
- Visual or hearing impairment that would hinder communication
- Emergency surgery or anticipated intraoperative complications
Where it is running
2 locations listed.
- Al-Azhar University - Baghdad, Baghdad Governorate, Iraq
- Al-Azhar University - Cairo, Egypt, Egypt